tiprankstipranks
Trending News
More News >
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market

Enliven Therapeutics (ELVN) Cash flow

Compare
306 Followers

Enliven Therapeutics Cash Flow

ELVN's free cash flow for Q3 2025 was $-13.28M. For the 2025 fiscal year, ELVN's free cash flow was decreased by $-11.82M and operating cash flow was $-13.28M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -73.19M$ -61.27M$ -32.08M$ -19.13M$ -8.53M
Investing Cash Flow
$ -36.00M$ -148.41M$ -612.00K$ -191.00K$ -461.00K
Financing Cash Flow
$ 133.16M$ 234.29M$ -1.80M$ -1.02M$ 130.51M
End Cash Position
$ 124.17M$ 100.19M$ 75.59M$ 110.08M$ 130.42M
Free Cash Flow
$ -73.24M$ -61.42M$ -32.69M$ -19.32M$ -8.99M
Currency in USD

Enliven Therapeutics Cash Flow